相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Aspirin Reduces the Incidence of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Receiving Oral Nucleos(t)ide Analog
Vicki Wing-Ki Hui et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2021)
Systematic review with meta-analysis: The effects of non-steroidal anti-inflammatory drugs and anti-platelet therapy on the incidence and recurrence of hepatocellular carcinoma
Regina Zi Hwei Tan et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2021)
Association of aspirin and statin use with the risk of liver cancer in chronic hepatitis B: A nationwide population-based study
Won-Mook Choi et al.
LIVER INTERNATIONAL (2021)
Epidemiological and etiological variations in hepatocellular carcinoma
Evangelista Sagnelli et al.
INFECTION (2020)
Aspirin decreases hepatocellular carcinoma risk in hepatitis C virus carriers: a nationwide cohort study
Yen-Hsiang Liao et al.
BMC GASTROENTEROLOGY (2020)
Risk factors for hepatocellular carcinoma (HCC) in the northeast of the United States: results of a case-control study
Yi Shen et al.
CANCER CAUSES & CONTROL (2020)
Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis
Sangdeok Shin et al.
MEDICINE (2020)
Tumour evolution in hepatocellular carcinoma
Amanda J. Craig et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Association of aspirin therapy with risk of hepatocellular carcinoma: A systematic review and dose-response analysis of cohort studies with 2.5 million participants
Shuijing Wang et al.
PHARMACOLOGICAL RESEARCH (2020)
Association of Daily Aspirin Therapy With Hepatocellular Carcinoma Risk in Patients With Chronic Hepatitis C Virus Infection
Teng-Yu Lee et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)
Association of Aspirin with Hepatocellular Carcinoma and Liver-Related Mortality
Tracey G. Simon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Use of metformin and aspirin is associated with delayed cancer incidence
Joseph J. Y. Sung et al.
CANCER EPIDEMIOLOGY (2020)
Association of Daily Aspirin Therapy With Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B
Teng-Yu Lee et al.
JAMA INTERNAL MEDICINE (2019)
Effect of low-dose aspirin administration on long-term survival of cirrhotic patients after splenectomy: A retrospective single-center study
Zhao-Qing Du et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Long-term use of low-dose aspirin for cancer prevention: A 10-year population cohort study in Hong Kong
Kelvin K. F. Tsoi et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
An Tang et al.
ABDOMINAL RADIOLOGY (2018)
Associations between aspirin use and the risk of cancers: a meta-analysis of observational studies
Yan Qiao et al.
BMC CANCER (2018)
Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes
Chin-Hsiao Tseng
LIVER INTERNATIONAL (2018)
Aspirin Use and Risk of Hepatocellular Carcinoma in a National Cohort Study of Korean Adults
In Cheol Hwang et al.
SCIENTIFIC REPORTS (2018)
Nonsteroidal anti-inflammatory drugs, especially aspirin, are linked to lower risk and better survival of hepatocellular carcinoma: a meta-analysis
Yuquan Tao et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Association Between Aspirin Use and Risk of Hepatocellular Carcinoma
Tracey G. Simon et al.
JAMA ONCOLOGY (2018)
Antiplatelet Therapy and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Antiviral Treatment
Minjong Lee et al.
HEPATOLOGY (2017)
Aspirin inhibits hepatitis C virus entry by downregulating claudin-1
P. Yin et al.
JOURNAL OF VIRAL HEPATITIS (2016)
Role of platelets in cancer and cancer-associated thrombosis: Experimental and clinical evidences
Soraya Mezouar et al.
THROMBOSIS RESEARCH (2016)
Lipid metabolic reprogramming in cancer cells
S. Beloribi-Djefaflia et al.
ONCOGENESIS (2016)
Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies
Luis A. Garcia Rodriguez et al.
PLOS ONE (2016)
NSAID Use and Risk of Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: The Liver Cancer Pooling Project
Jessica L. Petrick et al.
CANCER PREVENTION RESEARCH (2015)
Chronic hepatitis B: role of anti-platelet therapy in inflammation control
Roberto Aiolfi et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Role of Platelets in Inflammation and Cancer: Novel Therapeutic Strategies
Melania Dovizio et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2014)
Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: Current state-of-the science
Ibrahim Halil Sahin et al.
CANCER LETTERS (2014)
Anti-platelet therapy in the prevention of hepatitis B virus-associated hepatocellular carcinoma
Giovanni Sitia et al.
JOURNAL OF HEPATOLOGY (2013)
Nonsteroidal Anti-inflammatory Drug Use, Chronic Liver Disease, and Hepatocellular Carcinoma
Vikrant V. Sahasrabuddhe et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis B
Giovanni Sitia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Long-Term Use of Aspirin and the Risk of Gastrointestinal Bleeding
Edward S. Huang et al.
AMERICAN JOURNAL OF MEDICINE (2011)
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
Peter M. Rothwell et al.
LANCET (2011)
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
Peter M. Rothwell et al.
LANCET (2010)
Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement
David Moher et al.
INTERNATIONAL JOURNAL OF SURGERY (2010)
Acetylsalicylic acid inhibits hepatitis C virus RNA and protein expression through cyclooxygenase 2 signaling pathways
Karina Trujillo-Murillo et al.
HEPATOLOGY (2008)
Effects of acetylsalicylic acid and acetic acid solutions on VX2 liver carcinoma in rabbits.: In vivo analysis
Rogerio Saad-Hossne et al.
ACTA CIRURGICA BRASILEIRA (2007)
Calcium salicylate-mediated apoptosis in human HT-1080 fibrosarcoma cells
J. G. Mahdi et al.
CELL PROLIFERATION (2006)
Platelets mediate cytotoxic T lymphocyte-induced liver damage
M Iannacone et al.
NATURE MEDICINE (2005)
Aspirin and clopidogrel - Efficacy, safety, and the issue of drug resistance
M Cattaneo
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Measuring inconsistency in meta-analyses
JPT Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2003)
Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells
S Abiru et al.
HEPATOLOGY (2002)
Meta-analysis of observational studies in epidemiology - A proposal for reporting
DF Stroup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
